The ESMO Sarcoma and Rare Cancers Congress 2025 will provide: key insights into the diagnosis, prognostication, management and ongoing research of patients with rare adult solid cancers, sessions on multidisciplinary expert management, targeted therapies, precision medicine, methodological challenges, policy and guidelines, as well as sessions specifically designed for young investigators.
This is a specialised congress bringing together the worldwide sarcoma and rare cancers community providing a platform to collaborate and network with key opinion leaders in the field.
Fast Facts: ESMO Sarcoma and Rare Cancers Congress 2025
- Over 30 educational sessions
- Multiple Oral Abstract sessions (to be developed in January 2025)
- An internationally renowned faculty
- Unopposed Industry Satellite Symposia
- Numerous networking and engagement opportunities
How can I participate in the ESMO Sarcoma and Rare Cancers Congress 2025?
At ESMO we are committed to providing our industry partners with a variety of solutions to facilitate their presence at our congress.
Contact the ESMO Events Sponsorship Team for more details and we look forward to hearing from you!